CN121311513A - 葡聚糖与tlr7激动剂的缀合物 - Google Patents

葡聚糖与tlr7激动剂的缀合物

Info

Publication number
CN121311513A
CN121311513A CN202480039214.1A CN202480039214A CN121311513A CN 121311513 A CN121311513 A CN 121311513A CN 202480039214 A CN202480039214 A CN 202480039214A CN 121311513 A CN121311513 A CN 121311513A
Authority
CN
China
Prior art keywords
compound
cancer
integer
dextran
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480039214.1A
Other languages
English (en)
Chinese (zh)
Inventor
高梨洋辅
坂仁志
上町昊
永井康裕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of CN121311513A publication Critical patent/CN121311513A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202480039214.1A 2023-04-12 2024-04-11 葡聚糖与tlr7激动剂的缀合物 Pending CN121311513A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-065007 2023-04-12
JP2023065007 2023-04-12
PCT/JP2024/014657 WO2024214771A1 (ja) 2023-04-12 2024-04-11 デキストランとｔｌｒ７アゴニストのコンジュゲート体

Publications (1)

Publication Number Publication Date
CN121311513A true CN121311513A (zh) 2026-01-09

Family

ID=93059496

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480039214.1A Pending CN121311513A (zh) 2023-04-12 2024-04-11 葡聚糖与tlr7激动剂的缀合物

Country Status (4)

Country Link
JP (1) JPWO2024214771A1 (https=)
CN (1) CN121311513A (https=)
TW (1) TW202506187A (https=)
WO (1) WO2024214771A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011008A (en) * 1997-01-08 2000-01-04 Yissum Research Developement Company Of The Hebrew University Of Jerusalem Conjugates of biologically active substances
WO2017061532A1 (ja) * 2015-10-07 2017-04-13 大日本住友製薬株式会社 ピリミジン化合物
CN107304232B (zh) * 2017-05-20 2020-07-28 杭州师范大学 一种葡聚糖/吲哚美辛接枝物的合成方法与应用
US10722591B2 (en) * 2017-11-14 2020-07-28 Dynavax Technologies Corporation Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof

Also Published As

Publication number Publication date
JPWO2024214771A1 (https=) 2024-10-17
TW202506187A (zh) 2025-02-16
WO2024214771A1 (ja) 2024-10-17

Similar Documents

Publication Publication Date Title
JP2023071870A (ja) Ｔｌｒ作動薬化合物のマルチアームポリマーコンジュゲート及び関連の免疫療法治療の方法
AU2020270457B2 (en) Solid forms of (z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid
JP7085985B2 (ja) 悪性腫瘍治療用製剤及び組成物
WO2022228495A1 (zh) 抗体偶联药物的制备方法及应用
JP2023515034A (ja) 標的送達及び活性化した免疫刺激性複合体の調製と使用
US11708391B2 (en) Rapaglutins, novel inhibitors of GLUT and use thereof
KR20210113262A (ko) 패턴 인식 수용체 작용제의 컨쥬게이트
KR20150058554A (ko) 항암제의 전달을 위한 폴리머 시스템
JP2025084756A (ja) 治療用ナノ粒子を合成するための方法及び組成物
CN117500528A (zh) 连接子及其缀合物
CN113316452A (zh) 先天性免疫激动剂的持续局部药物水平
WO2024077277A1 (en) Drug linkers and antibody conjugates thereof
WO2024017229A1 (zh) 一种吡咯并三嗪类化合物在制备抗肿瘤药物中的应用
CN121311513A (zh) 葡聚糖与tlr7激动剂的缀合物
JP6461088B2 (ja) 高分子化カンプトテシン誘導体及び高分子化ｈｓｐ９０阻害剤誘導体を含む医薬組成物
CN119053607B (zh) 喜树碱类化合物及其偶联物、其制备方法和用途
WO2025148868A1 (zh) 一种抗体偶联药物及其用途
KR20260046445A (ko) 이미다조[4,5-d]피리다진 화합물 및 이의 접합체, 이의 제조 및 이의 치료적 적용
WO2015125640A1 (ja) カンプトテシン誘導体とｈｓｐ９０阻害剤の結合した高分子化合物及びその用途
CN120435477A (zh) 被取代的3,7-二氢-1h-嘌呤-2,6-二酮及其用途
WO2021216757A1 (en) Rna-binding protein multimerization inhibitors and methods of use thereof
CN105175411B (zh) 一种脲类化合物及其盐类化合物的合成方法和应用
KR20250010563A (ko) 다기능성 메타크릴레이트 글라이콜 키토산 하이드로젤 및 이의 용도
CN115716850A (zh) 芳基磷氧化合物的晶型、制备方法及用途
WO2025263617A1 (ja) コレステロールとｔｌｒ７アゴニストのコンジュゲート体およびそれを含む医薬組成物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination